loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Emricasan

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Emricasan

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Histogen and Amerimmune Announce Positive Results for Emricasan
    Histogen and Amerimmune Announce Positive Results for Emricasan

    22 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/22/2250903/0/en/Histogen-and-Amerimmune-Announce-Positive-Top-Line-Study-Results-from-its-Phase-1-Study-of-Emricasan-in-Mild-Symptomatic-COVID-19-Patients.html

    GLOBENEWSWIRE
    22 Jun 2021
    Share Share
    Conatus wields ax as Novartis-partnered NASH drug fails again
    Conatus wields ax as Novartis-partnered NASH drug fails again

    26 Jun 2019

    // Nick P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/conatus-wields-ax-as-novartis-partnered-nash-drug-fails-again

    Nick P. Taylor FIERCE BIOTECH
    26 Jun 2019
    Share Share
    Conatus grabs the ax and packs it in on NASH after a series of setbacks
    Conatus grabs the ax and packs it in on NASH after a series of setbacks

    24 Jun 2019

    // John Carroll ENDPTS

    https://endpts.com/suffering-novartis-partner-conatus-is-packing-it-in-on-nash-after-a-series-of-unfortunate-trial-events/

    John Carroll ENDPTS
    24 Jun 2019
    Share Share
    Novartis Inks Deal With Conatus Pharma For Chronic Liver Diseases
    Novartis Inks Deal With Conatus Pharma For Chronic Liver Diseases

    20 Dec 2016

    // NASDAQ

    http://www.nasdaq.com/article/novartis-inks-deal-with-conatus-pharma-for-chronic-liver-diseases-20161219-01011

    NASDAQ
    20 Dec 2016
    Share Share
    Conatus liver drug shows promise in mid-stage trial
    Conatus liver drug shows promise in mid-stage trial

    05 Jan 2016

    // Shailesh Kuber REUTERS

    http://www.reuters.com/article/us-conatus-trial-idUSKBN0UJ25U20160105

    Shailesh Kuber REUTERS
    05 Jan 2016
    Share Share